Table 2 Baseline characteristics of patients enrolled in the CRASH trial with Glasgow Outcome Scale score available
From: The added value of ordinal analysis in clinical trials: an example in traumatic brain injury
| Â | Corticosteroid (n= 4,800) | Placebo (n= 4,754) |
|---|---|---|
Age (median, IQR) | 33, 23 to 47 | 32, 23 to 48 |
Gender | ||
   Male | 3,892 (81.1%) | 3,824 (80.4%) |
Glasgow Coma Scale | ||
   Severe (3 to 8) | 1,925 (40.1%) | 1,890 (39.8%) |
   Moderate (9 to 12) | 1,477 (30.8%) | 1,405 (29.6%) |
   Mild (13 to 14) | 1,398 (29.1%) | 1,459 (30.7%) |
Pupillary reactivity | ||
   Both reactive to light | 3,860 (80.4%) | 3,822 (80.4%) |
   One reactive to light | 270 (5.6%) | 294 (6.2%) |
   Both not reactive to light | 412 (8.6%) | 387 (8.1%) |
   Missing | 258 (5.4%) | 251 (5.3%) |
Major extracranial injury | ||
   Yes | 1,106 (23.0%) | 1,039 (21.9%) |
   No | 3,600 (75.0%) | 3,613 (76.0%) |
   Missing | 94 (2.0%) | 102 (2.1%) |